|
UPSIDE Foods, a company that makes cell-cultured chicken by
harvesting cells from live animals and using the cells to grow
meat in stainless-steel tanks, will be able to bring its
products to market once it has been inspected by the U.S.
Department of Agriculture (USDA), said a release from the FDA.
"The world is experiencing a food revolution and the (FDA) is
committed to supporting innovation in the food supply," said FDA
Commissioner Robert M. Califf and Susan Mayne, director of the
FDA's Center for Food Safety and Applied Nutrition in a
statement.
The FDA said in documents released on Wednesday that it had
reviewed data from the company and had no further questions
about the company's conclusion that its product is safe for
humans to eat.
"We are thrilled at FDA's announcement," said David Kay,
UPSIDE's director of communications, in an email. "This historic
step paves the way for our path to market."
The review is not technically an approval and applies only to
UPSIDE products, though the agency is ready to work with other
firms developing cultured animal cell food, the FDA said in a
release.
USDA and FDA together regulate cell-cultured meat under a 2019
agreement between the two agencies. USDA will oversee the
processing and labeling of cell-cultured meat products.
Demand for alternatives to farmed meat has grown alongside
awareness of the high greenhouse gas emissions of raising
livestock. Cultivated chicken was served to attendees at this
year's COP27 climate conference in Egypt.
(Reporting by Leah Douglas; Editing by Josie Kao)
[© 2022 Thomson Reuters. All rights
reserved.] Copyright 2022 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|
